Healthcare
Ultragenyx Pharmaceutical (RARE)
Ultragenyx Pharmaceutical stock analysis and opportunity scoring
$26.53
↑ +2.79%
Ultragenyx Pharmaceutical (RARE) at a glance
Ultragenyx Pharmaceutical (RARE) is a publicly traded company in the Healthcare - Biotechnology sector tracked by MKD Intelligence.
RARE last traded at $24.91 as of 2026-09-04.
MKD Intelligence assigns RARE a composite opportunity score of 67 out of 100, indicating favourable conditions across trend, momentum and volume factors.
The risk score for RARE is 55 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$26.96
Low
$24.91
Period
Sep 2 - Jul 31 (24d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
'Fall From Grace' — Biotech Crashes 47% To A Record Low - Investor's Business Daily
Investor's Business Daily · 1d ago
Upcoming Events
Data as of Sep 4
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.